Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

    Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

    FromCell & Gene: The Podcast

    Start listeningView podcast show

    Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

    FromCell & Gene: The Podcast

    ratings:
    Length:
    25 minutes
    Released:
    Mar 17, 2022
    Format:
    Podcast episode

    Description

    BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.
    Released:
    Mar 17, 2022
    Format:
    Podcast episode

    Titles in the series (76)

    Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.